scholarly journals Occupational class differences in pancreatic cancer survival: A population‐based cancer registry‐based study in Japan

2019 ◽  
Author(s):  
Masayoshi Zaitsu ◽  
Yongjoo Kim ◽  
Hye‐Eun Lee ◽  
Takumi Takeuchi ◽  
Yasuki Kobayashi ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Registry ◽  
Cancer Survival ◽  
Population Based ◽  
Occupational Class ◽  
Class Differences

scholarly journals Does access to care play a role in liver cancer survival? The ten-year (2006–2015) experience from a population-based cancer registry in Southern Italy

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Walter Mazzucco ◽  
Francesco Vitale ◽  
Sergio Mazzola ◽  
Rosalba Amodio ◽  
Maurizio Zarcone ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Access To Care ◽  
Cancer Registry ◽  
Health Care Services ◽  
Cancer Survival ◽  
Developed Countries ◽  
Population Based ◽  
Easy Access ◽  
Net Survival ◽  
Poor Access

Abstract Background Hepatocellular carcinoma (HCC) is the most frequent primary invasive cancer of the liver. During the last decade, the epidemiology of HCC has been continuously changing in developed countries, due to more effective primary prevention and to successful treatment of virus-related liver diseases. The study aims to examine survival by level of access to care in patients with HCC, for all patients combined and by age. Methods We included 2018 adult patients (15–99 years) diagnosed with a primary liver tumour, registered in the Palermo Province Cancer Registry during 2006–2015, and followed-up to 30 October 2019. We obtained a proxy measure of access to care by linking each record to the Hospital Discharge Records and the Ambulatory Discharge Records. We estimated net survival up to 5 years after diagnosis by access to care (“easy access to care” versus “poor access to care”), using the Pohar-Perme estimator. Estimates were age-standardised using International Cancer Survival Standard (ICSS) weights. We also examined survival by access to care and age (15–64, 65–74 and ≥ 75 years). Results Among the 2018 patients, 62.4% were morphologically verified and 37.6% clinically diagnosed. Morphologically verified tumours were more frequent in patients aged 65–74 years (41.6%), while tumours diagnosed clinically were more frequent in patients aged 75 years or over (50.2%). During 2006–2015, age-standardised net survival was higher among HCC patients with “easy access to care” than in those with “poor access to care” (68% vs. 48% at 1 year, 29% vs. 11% at 5 years; p < 0.0001). Net survival up to 5 years was higher for patients with “easy access to care” in each age group (p < 0.0001). Moreover, survival increased slightly for patients with easier access to care, while it remained relatively stable for patients with poor access to care. Conclusions During 2006–2015, 5-year survival was higher for HCC patients with easier access to care, probably reflecting progressive improvement in the effectiveness of health care services offered to these patients. Our linkage algorithm could provide valuable evidence to support healthcare decision-making in the context of the evolving epidemiology of hepatocellular carcinoma.

scholarly journals Occupational disparities in bladder cancer survival: A population‐based cancer registry study in Japan

2019 ◽  
Vol 9 (3) ◽  
pp. 894-901 ◽  
Author(s):  
Masayoshi Zaitsu ◽  
Hye‐Eun Lee ◽  
Sangchul Lee ◽  
Takumi Takeuchi ◽  
Yasuki Kobayashi ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Registry ◽  
Cancer Survival ◽  
Population Based ◽  
Registry Study ◽  
Occupational Disparities

scholarly journals Geographical residency influences pancreatic cancer survival: a Danish nationwide population-based cohort study

HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S533
Author(s):  
J. Kirkegård ◽  
M. Ladekarl ◽  
C.W. Fristrup ◽  
C. Palnæs-Hansen ◽  
M. Sall ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cohort Study ◽  
Cancer Survival ◽  
Population Based

scholarly journals Urban versus rural residency and pancreatic cancer survival: A Danish nationwide population-based cohort study

PLoS ONE ◽  
2018 ◽  
Vol 13 (8) ◽  
pp. e0202486 ◽  
Author(s):  
Jakob Kirkegård ◽  
Morten Ladekarl ◽  
Claus Wilki Fristrup ◽  
Carsten Palnæs Hansen ◽  
Mogens Sall ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cohort Study ◽  
Cancer Survival ◽  
Population Based ◽  
Rural Residency ◽  
Urban Versus

scholarly journals Differences in cancer survival by area-level socio-economic disadvantage: A population-based study using cancer registry data

PLoS ONE ◽  
2020 ◽  
Vol 15 (1) ◽  
pp. e0228551 ◽  
Author(s):  
Nina Afshar ◽  
Dallas R. English ◽  
Tony Blakely ◽  
Vicky Thursfield ◽  
Helen Farrugia ◽  
...  
Keyword(s):  
Cancer Registry ◽  
Cancer Survival ◽  
Population Based ◽  
Registry Data ◽  
Economic Disadvantage ◽  
Population Based Study ◽  
Cancer Registry Data

scholarly journals The Incidence and Survival Rate of Population-Based Pancreatic Cancer Patients: Shanghai Cancer Registry 2004–2009

PLoS ONE ◽  
2013 ◽  
Vol 8 (10) ◽  
pp. e76052 ◽  
Author(s):  
Jianfeng Luo ◽  
Linhai Xiao ◽  
Chunxiao Wu ◽  
Ying Zheng ◽  
Naiqing Zhao
Keyword(s):  
Pancreatic Cancer ◽  
Survival Rate ◽  
Cancer Patients ◽  
Cancer Registry ◽  
Population Based

scholarly journals Occupational Class Differences in Long-Term Sickness Absence Due to Breast Cancer during 2005–2013: A Population-Based Study among Finnish Women

2019 ◽  
Vol 16 (18) ◽  
pp. 3477
Author(s):  
Johanna Suur-Uski ◽  
Johanna Pekkala ◽  
Jenni Blomgren ◽  
Olli Pietiläinen ◽  
Ossi Rahkonen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Sickness Absence ◽  
Cumulative Incidence ◽  
Breast Cancer Incidence ◽  
Work Capacity ◽  
Population Based ◽  
Occupational Class ◽  
Class Differences ◽  
Nationally Representative ◽  
Changes Over Time

Breast cancer is the most common cancer among women in Western countries with clear socioeconomic differences. Higher occupational class is associated with higher breast cancer incidence but with better survival from the disease, whereas lower occupational class is associated with higher risk of sickness absence. We are not aware of previous studies examining changes over time in occupational class differences in sickness absence due to breast cancer. This paper focuses on occupational class differences in the incidence and duration of sickness absence due to breast cancer over the period of 2005–2013. Age-adjusted occupational class differences in the cumulative incidence and duration of sickness absence due to breast cancer were calculated utilising a nationally representative 70% random sample of employed Finnish women aged 35–64 years (yearly N varying between 499,778 and 519,318). The results show that higher occupational class was associated with higher annual cumulative incidence of sickness absence due to breast cancer. Lower occupational class was associated with longer duration of absence. Occupational class differences in both cumulative incidence and duration of absence remained broadly stable. As a conclusion, these results suggest that measures should be targeted particularly to promotion of work capacity among employees with breast cancer in lower occupational classes.

Pancreatic cancer survival trends overall, by stage, and histologic sub-type: An analysis of Surveillance, Epidemiology and End Results (SEER) population-based data (2000-2015).

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e15772-e15772 ◽  
Author(s):  
Parisa Karimi ◽  
Vanessa L Gordon-Dseagu ◽  
Pavel Chernyavskiy ◽  
Michael Goggins ◽  
Philip S. Rosenberg ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Metastatic Disease ◽  
Cancer Survival ◽  
Comprehensive Evaluation ◽  
Credible Interval ◽  
The United States ◽  
Population Based ◽  
Ductal Adenocarcinoma ◽  
Significant Heterogeneity ◽  
Not Otherwise Specified

e15772 Background: Pancreatic cancer (PC) is the third leading cause of cancer mortality in the United States, with an overall relative 5-year survival rate of 8.2%. We conducted a comprehensive evaluation of survival trends after PC diagnosis overall and by stage and histologic sub-type. Methods: We conducted a retrospective, population-based study of 91,234 PC cases using nationally representative data from the SEER program to evaluate 5-year survival trends by histologic sub-type from 2000 to 2015. Our model incorporated sub-type-specific random intercepts to effectively stabilize survival estimates by borrowing information across all sub-types. The estimation was performed in a fully Bayesian setting in R. Results: Adenocarcinoma, not otherwise specified (NOS) and ductal adenocarcinomas comprised 81% of PC. Cancer stage and histologic sub-type were both important factors in explaining variability in 5-year survival. We observed a consistent ordering of cancer stages within each histologic sub-type from highest to lowest survival for local, regional, and metastatic disease, respectively. Adenocarcinoma not otherwise specified, ductal adenocarcinoma, ductal specified as mucinous, and poorly specified type had the lowest 5-year survival with fitted ranges of 25-35% for localized, 5-19% for regional and < 4% for metastatic disease. Ductal arising from intraductal papillary mucinous neoplasm, ductal specified as cystic, acinar cell, other adenocarcinoma, and non-carcinomas had intermediate 5-year survival of 54-75%; while endocrine non-secretory or neuroendocrine, endocrine secretory, carcinoid, and solid pseudopapillary cancers had the best survival (87-98%). On average, across histologic sub-types, PC survival improved by 0.5% (90% credible interval 0.01%, 1.0%) per year, or 5.1% (0.1%, 10.0%) per decade. Some improvement in fitted survival occurred across all stages and histologic sub-types. Conclusions: Overall survival for patients with PC has improved by around 5% per decade from 2000 to 2015, with significant heterogeneity by histologic sub-type.

Sign in / Sign up

Export Citation Format

Share Document